- Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability of oncology cell therapies -
- Abstracts include new preclinical data demonstrating ongoing progress from collaboration with BlueRock Therapeutics and new technology development to enable Senti's future oncology pipeline products -
SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases using its proprietary Gene Circuit platform, today announced four poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, being held November 1-5, 2023, in San Diego, CA.
Information about the poster sessions is as follows:
NOT gate gene circuits expand the range of tumor-associated antigens addressable by CAR-NK and -T cell therapies
In collaboration with GeneFab LLC
Abstract number: 257
Location: Poster Halls A and B1
Date and time: November 3, 2023, 9:00 am - 7:00 pm PT
Small-molecule regulated safety switch for improved safety of CAR cell therapies in the brain
In collaboration with BlueRock Therapeutics and GeneFab LLC
Abstract number: 24
Location: Poster Halls A and B1
Date and time: November 4, 2023, 9:00 am - 8:30 pm PT
Smart sensor promoters drive state-specific gene circuits to convert immunosuppressive macrophages into an anti-tumor phenotype
In collaboration with BlueRock Therapeutics and GeneFab LLC
Abstract number: 430
Location: Poster Halls A and B1
Date and time: November 4, 2023, 9:00 am - 8:30 pm PT
High-throughput discovery of constitutive promoters to drive strong expression of next-generation gene circuits in CAR-NK and -T cells
Abstract number: 270
Location: Poster Halls A and B1
Date and time: November 4, 2023, 9:00 am - 8:30 pm PT
Following the presentations, copies of the poster presentations will be available on the Scientific Presentations & Publications section of the Senti Bio website.
About Senti Bio
Senti Biosciences is a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases. To achieve this, Senti Bio is leveraging a synthetic biology platform called Gene Circuits to create therapies with enhanced precision and control. These Gene ...